92 related articles for article (PubMed ID: 2582838)
1. The cardiovascular effects of inhaled fenoterol alone and during treatment with oral theophylline.
Flatt A; Burgess C; Windom H; Beasley R; Purdie G; Crane J
Chest; 1989 Dec; 96(6):1317-20. PubMed ID: 2582838
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
Crane J; Burgess C; Beasley R
Thorax; 1989 Feb; 44(2):136-40. PubMed ID: 2928998
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular effects of fenoterol under conditions of hypoxaemia.
Bremner P; Burgess CD; Crane J; McHaffie D; Galletly D; Pearce N; Woodman K; Beasley R
Thorax; 1992 Oct; 47(10):814-7. PubMed ID: 1481183
[TBL] [Abstract][Full Text] [Related]
4. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
[TBL] [Abstract][Full Text] [Related]
5. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.
Flatt A; Crane J; Purdie G; Kwong T; Beasley R; Burgess C
Postgrad Med J; 1990 Feb; 66(772):98-101. PubMed ID: 2349198
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol.
Bremner P; Woodman K; Burgess C; Crane J; Purdie G; Pearce N; Beasley R
Eur Respir J; 1993 Feb; 6(2):204-10. PubMed ID: 8095240
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
[TBL] [Abstract][Full Text] [Related]
8. Effects of atenolol vs diltiazem on the haemodynamic effects of an inhaled beta 2-adrenoceptor agonist.
Chapman KR; Galko BM; Smith DL; Leenen FH
Br J Clin Pharmacol; 1989 Feb; 27(2):268-71. PubMed ID: 2713221
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of an inhaled beta-2 agonist.
Chapman KR; Smith DL; Rebuck AS; Leenen FH
Clin Pharmacol Ther; 1984 Jun; 35(6):762-7. PubMed ID: 6734028
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator effect and serum theophylline level after combined treatment with fenoterol and theophylline in reversible chronic airflow obstruction.
Lucena MI; Almagro J; Rius F; Sanchez de la Cuesta F
Eur J Clin Pharmacol; 1988; 35(6):669-71. PubMed ID: 3234474
[TBL] [Abstract][Full Text] [Related]
11. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
Deenstra M; Haalboom JR; Struyvenberg A
Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
[TBL] [Abstract][Full Text] [Related]
12. Partial vs full beta-receptor agonism. A clinical study of inhaled albuterol and fenoterol.
Bremner P; Siebers R; Crane J; Beasley R; Burgess C
Chest; 1996 Apr; 109(4):957-62. PubMed ID: 8635377
[TBL] [Abstract][Full Text] [Related]
13. Oral fenoterol versus sustained release theophylline in adult asthmatics.
Lucena MI; Almagro J; Andrade RJ; Hidalgo Sanchez R; Sanchez de la Cuesta F
Int J Clin Pharmacol Ther; 1997 Jan; 35(1):19-23. PubMed ID: 9021437
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilator effect of theophylline preparations and aerosol fenoterol in stable asthma.
Magnussen H; Jörres R; Hartmann V
Chest; 1986 Nov; 90(5):722-5. PubMed ID: 3533455
[TBL] [Abstract][Full Text] [Related]
15. Additive effect of theophylline on the cardiac response to isoproterenol.
Cusack BJ; Nielson CP; Morgan ME; Vestal RE
Clin Pharmacol Ther; 1987 Mar; 41(3):289-96. PubMed ID: 3816017
[TBL] [Abstract][Full Text] [Related]
16. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.
Scheinin M; Koulu M; Laurikainen E; Allonen H
Br J Clin Pharmacol; 1987 Nov; 24(5):645-53. PubMed ID: 2829953
[TBL] [Abstract][Full Text] [Related]
17. Abnormal myocardial repolarisation in response to hypoxaemia and fenoterol.
Kiely DG; Cargill RI; Grove A; Struthers AD; Lipworth BJ
Thorax; 1995 Oct; 50(10):1062-6. PubMed ID: 7491554
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator action of inhaled fenoterol and ipratropium in normal subjects: a teaching exercise for medical students.
Taylor RG; Maclagan J; Cook DG
Br J Clin Pharmacol; 1989 Dec; 28(6):709-13. PubMed ID: 2532922
[TBL] [Abstract][Full Text] [Related]
19. Comparative dose-response study of three anticholinergic agents and fenoterol using a metered dose inhaler in patients with chronic obstructive pulmonary disease.
Ikeda A; Nishimura K; Koyama H; Izumi T
Thorax; 1995 Jan; 50(1):62-6. PubMed ID: 7886652
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of inhaled ipratropium bromide, alone and combined with an inhaled beta 2-agonist.
Chapman KR; Smith DL; Rebuck AS; Leenen FH
Am Rev Respir Dis; 1985 Oct; 132(4):845-7. PubMed ID: 2864891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
